Cargando…

KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway

Background: Cancer stem cells (CSCs) are highly tumorigenic, chemotherapy-resistant, tumor growth-sustaining, and are implicated in tumor recurrence. Previous studies have shown that lysine-specific histone demethylase 1A (KDM1A) is highly expressed in several human malignancies and CSCs. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Ruan, Xianhui, Li, Yaoshuang, Zhi, Jingtai, Hu, Linfei, Hou, Xiukun, Shi, Xianle, Wang, Xin, Wang, Jinpeng, Ma, Weike, Gu, Pengfei, Zheng, Xiangqian, Gao, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825597/ https://www.ncbi.nlm.nih.gov/pubmed/35198054 http://dx.doi.org/10.7150/thno.66142

Ejemplares similares

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
por: Hu, Linfei, et al.
Publicado: (2022)

Functional analysis and clinical significance of the isocitrate dehydrogenase 2 gene in papillary thyroid carcinoma
por: Zhang, Jun, et al.
Publicado: (2019)

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
por: Hou, Xiukun, et al.
Publicado: (2021)

Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer
por: Tang, Tao, et al.
Publicado: (2022)

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer
por: Ma, Weike, et al.
Publicado: (2023)

Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: a study of 1579 cases: a retrospective study
por: Wang, Huijuan, et al.
Publicado: (2020)

Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer
por: Zhang, Jun, et al.
Publicado: (2021)

Antitumor effects of anlotinib in thyroid cancer
por: Ruan, Xianhui, et al.
Publicado: (2018)

Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway
por: Zhao, Zewei, et al.
Publicado: (2022)

Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis
por: Jingtai, Zhi, et al.
Publicado: (2023)

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
por: Meng, Xiangrui, et al.
Publicado: (2020)

Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer
por: Xie, Wenjun, et al.
Publicado: (2021)

FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer
por: Qiu, Li, et al.
Publicado: (2020)

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
por: Gu, Pengfei, et al.
Publicado: (2022)

Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
por: Zheng, Xiangqian, et al.
Publicado: (2019)

PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause
por: Hou, Xiukun, et al.
Publicado: (2023)

Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects
por: Gu, Pengfei, et al.
Publicado: (2022)

Histone demethylase KDM6B inhibits breast cancer metastasis by regulating Wnt/β‐catenin signaling
por: Xun, Jing, et al.
Publicado: (2021)

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments
por: Sun, Ying, et al.
Publicado: (2022)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes
por: Zhi, Jingtai, et al.
Publicado: (2020)

KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
por: Li, Jiong, et al.
Publicado: (2017)

Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer
por: Hao, Weijing, et al.
Publicado: (2023)

KDM3A and KDM3B Maintain Naïve Pluripotency Through the Regulation of Alternative Splicing
por: Dillingham, Caleb, et al.
Publicado: (2023)

Author Correction: KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
por: Li, Jiong, et al.
Publicado: (2019)

Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer
por: Zeng, Yu, et al.
Publicado: (2023)

Diagnosis and treatment of ectopic thyroid carcinoma: A case report and literature review
por: Fu, Guiming, et al.
Publicado: (2022)

Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling
por: Lađinović, Dijana, et al.
Publicado: (2020)

Bcl-3 promotes Wnt signaling by maintaining the acetylation of β-catenin at lysine 49 in colorectal cancer
por: Chen, Xi, et al.
Publicado: (2020)

Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis
por: Liu, Ming Ming, et al.
Publicado: (2020)

KDM1A maintains genome-wide homeostasis of transcriptional enhancers
por: Agarwal, Saurabh, et al.
Publicado: (2021)

Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases
por: Zhi, Jingtai, et al.
Publicado: (2017)

Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles
por: Wei, Songfeng, et al.
Publicado: (2019)

Histone demethylase Kdm5c regulates osteogenesis and bone formation via PI3K/Akt/HIF1α and Wnt/β-catenin signaling pathways
por: Li, Ying, et al.
Publicado: (2023)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2020)

KDM2B regulates hippocampal morphogenesis by transcriptionally silencing Wnt signaling in neural progenitors
por: Zhang, Bo, et al.
Publicado: (2023)

High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion
por: Zhao, Jingzhu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rcl0et0g16n2vi93f35cuuhhvq